Table 5

 Factors used to assess efficacy and need for ongoing TNF inhibitor therapy*

Response (mean)
*n = 880 (online survey, US rheumatologists, April 2005).
Respondents were asked to rank these on a scale of 1–8 from most important (1) to never important (8).
Physician joint examination1.69
Patient assessment of response1.88
Drug tolerability2.04
Physician global assessment2.14
Radiographic assessments2.94
Erythrocyte sedimentation rate or C-reactive protein3.18
Functional outcome measures4.20
Disease Activity Score (DAS)5.41